Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
52,265,866
-
Total 13F shares
-
12,649,378
-
Share change
-
+265,273
-
Total reported value
-
$14,167,341
-
Price per share
-
$1.12
-
Number of holders
-
43
-
Value change
-
+$297,645
-
Number of buys
-
13
-
Number of sells
-
6
Institutional Holders of ENZO BIOCHEM INC - Common Stock (ENZB) as of Q3 2024
As of 30 Sep 2024,
ENZO BIOCHEM INC - Common Stock (ENZB) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,649,378 shares.
The largest 10 holders included
HARBERT FUND ADVISORS, INC., RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, RBF Capital, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and WITTENBERG INVESTMENT MANAGEMENT, INC..
This page lists
43
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.